Johnson & Johnson Reports Solid Financial Performance in Q2 2023, with Net Earnings of $5.14 Billion
Company's Q2 Revenue Reaches $25.53 Billion, Marking a Steady Growth
Johnson & Johnson,(JNJ) a global leader in the healthcare industry, has released its consolidated financial statements for the second quarter of 2023. The report showcases the company's robust financial performance, highlighted by net earnings of $5.14 billion. Furthermore, the company's revenue for the quarter reached $25.53 billion, demonstrating consistent growth.
Consolidated Balance Sheets Reflect Strong Asset Base
The consolidated balance sheets reveal a strong asset base for Johnson & Johnson. As of July 2, 2023, the company's total assets stand at $191.69 billion, an increase from $187.38 billion at the beginning of the year. Current assets, including cash and cash equivalents, marketable securities, accounts receivable, trade, inventories, and prepaid expenses, totaled $60.57 billion.
